Systematic review of ophthalmate as a novel biomarker of hepatic glutathione depletion

Clinical Nutrition

Volumn 32, Issue 3, 2013, Pages 325-330

  Dello, Simon A W G ^a   Neis, Evelien P J G ^a   de Jong, Mechteld C ^a   van Eijk, Hans M H ^a   Kicken, Cécile H ^a   Olde Damink, Steven W M ^a,b   Dejong, Cornelis H C ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Glutathione; Hepatotoxicity; LC MS MS; Ophthalmate

Indexed keywords

BIOLOGICAL MARKER; DEUTERIUM OXIDE; GLUTATHIONE; GLUTATHIONE DERIVATIVE; OPHTHALMATE; PARACETAMOL; UNCLASSIFIED DRUG;

DISEASE MODEL; HEPATIC GLUTATHIONE DEPLETION; HUMAN; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; LIVER LEVEL; LIVER TOXICITY; MASS SPECTROMETRY; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN STABILITY; PROTEIN SYNTHESIS; REVIEW; SYSTEMATIC REVIEW;

ACETAMINOPHEN; ANIMALS; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; DEUTERIUM OXIDE; GLUTATHIONE; HUMANS; LIVER; MASS SPECTROMETRY; MICE; OLIGOPEPTIDES; OXIDATIVE STRESS;

EID: 84877107888     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2012.10.008     Document Type: Review

References (26)

1. Hinson J.A., Reid A.B., McCullough S.S., James L.P. Acetaminophen-induced hepatotoxicity: role of metabolic activation, reactive oxygen/nitrogen species, and mitochondrial permeability transition. Drug Metab Rev 2004, 36(3-4):805-822.
2. Biolo G., Antonione R., De Cicco M. Glutathione metabolism in sepsis. Crit Care Med 2007, 35(Suppl. 9):S591-S595.
3. Hammond C.L., Lee T.K., Ballatori N. Novel roles for glutathione in gene expression, cell death, and membrane transport of organic solutes. J Hepatol 2001, 34(6):946-954.
4. Abbas R., Kombu R.S., Ibarra R.A., Goyal K.K., Brunengraber H., Sanabria J.R. The dynamics of glutathione species and ophthalmate concentrations in plasma from the VX2 rabbit model of secondary liver tumors. HPB Surg 2011, 709052.
5. Kombu R.S., Zhang G.F., Abbas R., Mieyal J.J., Anderson V.E., Kelleher J.K., et al. Dynamics of glutathione and ophthalmate traced with 2H-enriched body water in rats and humans. Am J Physiol Endocrinol Metab 2009, 297(1):E260-E269.
6. Soga T., Baran R., Suematsu M., Ueno Y., Ikeda S., Sakurakawa T., et al. Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption. J Biol Chem 2006, 281(24):16768-16776.
7. Geenen S., du Preez F.B., Reed M., Frederik Nijhout H., Gerry Kenna J., Wilson I.D., et al. A mathematical modelling approach to assessing the reliability of biomarkers of glutathione metabolism. Eur J Pharm Sci 2012, 16(4):233-243.
8. Geenen S., Michopoulos F., Kenna J.G., Kolaja K.L., Westerhoff H.V., Wilson I. HPLC-MS/MS methods for the quantitative analysis of ophthalmic acid in rodent plasma and hepatic cell line culture medium. J Pharm Biomed Anal 2011, 54(5):1128-1135.
9. New L.S., Chan E.C. Evaluation of BEH C18, BEH HILIC, and HSS T3 (C18) column chemistries for the UPLC-MS-MS analysis of glutathione, glutathione disulfide, and ophthalmic acid in mouse liver and human plasma. J Chromatogr Sci 2008, 46(3):209-214.
10. Andres Ibarra R., Abbas R., Kombu R.S., Zhang G.F., Jacobs G., Lee Z., et al. Disturbances in the glutathione/ophthalmate redox buffer system in the woodchuck model of hepatitis virus-induced hepatocellular carcinoma. HPB Surg 2011, 789323.
11. Hahn R., Wendel A., Flohe L. The fate of extracellular glutathione in the rat. Biochim Biophys Acta 1978, 539(3):324-337.
12. Ballatori N., Dutczak W.J. Identification and characterization of high and low affinity transport systems for reduced glutathione in liver cell canalicular membranes. J Biol Chem 1994, 269(31):19731-19737.
13. Circu M.L., Stringer S., Rhoads C.A., Moyer M.P., Aw T.Y. The role of GSH efflux in staurosporine-induced apoptosis in colonic epithelial cells. Biochem Pharmacol 2009, 77(1):76-85.
14. Sethna S.S., Gander J.E., Rathbun W.B. Glutathione synthetase of bovine lens: anomalies of the enzyme-catalyzed formation of ophthalmic acid. Curr Eye Res 1984, 3(7):923-928.
15. Tsuboi S., Hirota K., Ogata K., Ohmori S. Ophthalmic and norophthalmic acid in lens, liver, and brain of higher animals. Anal Biochem 1984, 136(2):520-524.
16. Offord R.E., Philippe J., Davis J.G., Halban P.A., Berger M. Inhibition of degradation of insulin by ophthalamic acid and by a bovine pancreatic proteinase inhibitor. Biochem J 1979, 182(1):249-251.
17. Orlowski M., Wilk S. Synthesis of ophthalmic acid in liver and kidney in vivo. Biochem J 1978, 170(2):415-419.
18. Letelier ME, Lopez-Valladares M, Peredo-Silva L, Rojas-Sepulveda D, Aracena P. Microsomal oxidative damage promoted by acetaminophen metabolism. Toxicol In Vitro.
19. Hayes J.D., McLellan L.I. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res 1999, 31(4):273-300.
20. Paolicchi A., Dominici S., Pieri L., Maellaro E., Pompella A. Glutathione catabolism as a signaling mechanism. Biochem Pharmacol 2002, 64(5-6):1027-1035.
21. Meister A. Glutathione metabolism and its selective modification. J Biol Chem 1988, 263(33):17205-17208.
22. Kaplowitz N., Aw T.Y., Ookhtens M. The regulation of hepatic glutathione. Annu Rev Pharmacol Toxicol 1985, 25:715-744.
23. Waley S.G. Acidic peptides of the lens. 3. The structure of ophthalmic acid. Biochem J 1958, 68(1):189-192.
24. Cliffe E.E., Waley S.G. Acidic peptides of the lens. 4. The biosynthesis of ophthalmic acid. Biochem J 1958, 69(4):649-655.
25. Chun L.J., Tong M.J., Busuttil R.W., Hiatt J.R. Acetaminophen hepatotoxicity and acute liver failure. J Clin Gastroenterol 2009, 43(4):342-349.
26. Jalan R., Williams R., Bernuau J. Paracetamol: are therapeutic doses entirely safe?. Lancet 2006, 368(9554):2195-2196.